Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by GoldCoastCRon Aug 03, 2018 9:43am
29 Views
Post# 28409607

RE:RE:RE:RE:RE:Rev Tracker

RE:RE:RE:RE:RE:Rev Tracker All jammed into LAST YEAR the YEAR of Aquisitions causing massive revenue for this year with Q1 ON DECK!!!!!!!!

CLEAR AS DAY WHAT IS ABOUT TO HAPPEN TO ANY REAL LONG INVESTOR.


WeakHands wrote: To be more precise: 13 mils are consultancy fees, 11 mils are ACQUISITIONS fees and around 900k are management fees. 24.9 mils out of 36 mils are just FEES. All incurred in the last quarter.

The ER and MD&A has all the details you need.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities